| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | Spellman David A | SVP, CFO and Treasurer | May 16, 2023 | Sale | $1.07 | 63,567 | 67,890 | 446,483 | May 18, 2023, 06:19 PM | |
| AKBA | Akebia Therapeutics, Inc. | Spellman David A | SVP, CFO and Treasurer | Mar 01, 2023 | Sale | $0.88 | 7,210 | 6,327 | 510,860 | Mar 03, 2023, 08:00 AM | |
| AKBA | Akebia Therapeutics, Inc. | Spellman David A | SVP, CFO and Treasurer | Feb 27, 2023 | Sale | $0.81 | 7,539 | 6,131 | 517,260 | Mar 01, 2023, 04:05 PM | |
| AKBA | Akebia Therapeutics, Inc. | Spellman David A | SVP, CFO and Treasurer | Feb 28, 2022 | Sale | $2.15 | 7,400 | 15,946 | 69,402 | Mar 02, 2022, 09:09 PM | |
| AKBA | Akebia Therapeutics, Inc. | Spellman David A | SVP, CFO and Treasurer | Mar 01, 2022 | Sale | $2.17 | 803 | 1,743 | 128,599 | Mar 02, 2022, 09:09 PM | |
| AKBA | Akebia Therapeutics, Inc. | Spellman David A | SVP, CFO and Treasurer | Apr 01, 2021 | Sale | $3.40 | 790 | 2,686 | 76,802 | Apr 01, 2021, 08:34 PM |
Menu